Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$183.12 - $250.2 $423,556 - $578,712
-2,313 Reduced 2.11%
107,369 $26.9 Million
Q1 2023

Apr 26, 2023

BUY
$193.59 - $245.33 $618,326 - $783,584
3,194 Added 3.0%
109,682 $23.4 Million
Q4 2022

Feb 08, 2023

SELL
$173.9 - $224.8 $990,360 - $1.28 Million
-5,695 Reduced 5.08%
106,488 $20.7 Million
Q3 2022

Nov 03, 2022

SELL
$183.25 - $247.5 $402,050 - $543,015
-2,194 Reduced 1.92%
112,183 $19.3 Million
Q2 2022

Aug 10, 2022

SELL
$197.3 - $261.32 $485,358 - $642,847
-2,460 Reduced 2.11%
114,377 $24.8 Million
Q1 2022

May 09, 2022

SELL
$216.09 - $296.03 $261,901 - $358,788
-1,212 Reduced 1.03%
116,837 $28.4 Million
Q4 2021

Feb 08, 2022

SELL
$258.11 - $309.7 $4.92 Million - $5.91 Million
-19,078 Reduced 13.91%
118,049 $36.6 Million
Q3 2021

Nov 12, 2021

BUY
$208.53 - $283.04 $28.6 Million - $38.8 Million
137,127 New
137,127 $35.9 Million
Q1 2019

May 10, 2019

SELL
$121.3 - $146.95 $50.7 Million - $61.4 Million
-417,651 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$119.37 - $153.29 $4.85 Million - $6.23 Million
-40,643 Reduced 8.87%
417,651 $54 Million
Q3 2018

Nov 13, 2018

SELL
$131.3 - $153.75 $5.86 Million - $6.86 Million
-44,636 Reduced 8.88%
458,294 $70.5 Million
Q2 2018

Aug 02, 2018

SELL
$111.38 - $137.03 $1.13 Million - $1.39 Million
-10,121 Reduced 1.97%
502,930 $66.7 Million
Q1 2018

May 11, 2018

SELL
$103.82 - $123.9 $3.56 Million - $4.25 Million
-34,264 Reduced 6.26%
513,051 $60.6 Million
Q4 2017

Feb 09, 2018

SELL
$111.14 - $123.05 $4.46 Million - $4.93 Million
-40,089 Reduced 6.82%
547,315 $61.4 Million
Q3 2017

Nov 13, 2017

BUY
$101.4 - $116.62 $59.6 Million - $68.5 Million
587,404
587,404 $66.9 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.2B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.